Rivus Pharmaceuticals
Focus: Rivus Pharmaceuticals is a public-stage biotech focused on controlled metabolic accelerators targeting neurology and metabolic diseases. Founded in 2019 and headquartered in Charlottesville, VA, the company is advancing a pipeline centered on HU6 across multiple metabolic indications.
Profile data last refreshed 9h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Rivus Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Rivus Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
10 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
Post-loss-of-exclusivity generic morphine product with limited strategic value; likely a legacy or portfolio asset.
Help build intelligence for Rivus Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.